Visionworks Eyewear Supplier (Equipment, not the service) Location: 430 E Altamonte Dr, Altamonte Springs, Florida 32701 Phone: (407) 830-0087 |
Walmart Pharmacy 10-1374 Durable Medical Equipment & Medical Supplies Location: 200 S State Road 434, Altamonte Springs, Florida 32714 Phone: (407) 774-6255 |
Walgreens #16404 Durable Medical Equipment & Medical Supplies Location: 885 W State Road 436, Altamonte Springs, Florida 32714 Phone: (407) 389-7353 |
Walgreens #6922 Durable Medical Equipment & Medical Supplies Location: 113 Maitland Ave, Altamonte Springs, Florida 32701 Phone: (407) 331-4698 |
Walgreens #9016 Pharmacy Location: 200 W State Road 436, Altamonte Springs, Florida 32714 Phone: (407) 389-0476 |
Wellspring Regenerative Medicine Ll Medicare Supplier Location: 940 Centre Cir, Altamonte Springs, Florida 32714 Phone: (407) 789-0600 |
News Archive
Quantifying how sore a person is after a long workout is a challenge for doctors and researchers, but scientists from Loma Linda and Asuza Pacific Universities think they may have figured it out. Their research article describing a new technique to measure muscle soreness will be published in the Journal of Visualized Experiments.
Osiris Therapeutics, Inc., today provided an update on its Phase 2 trial evaluating Prochymal, a formulation of adult mesenchymal stem cells (MSCs), in patients with newly diagnosed type 1 diabetes.
Low estrogen levels may make women more susceptible to the development of post-traumatic stress disorder (PTSD) at some points in their menstrual cycles or lifetimes, while high estrogen levels may be protective.
Otsuka Pharmaceutical Co., Ltd. today announced it has become the first company in the world to obtain regulatory approval for a pharmacological treatment of autosomal dominant polycystic kidney disease (ADPKD). Samsca (generic name: tolvaptan) has been approved in Japan in 7.5-mg and 15-mg tablet forms for extended use for the additional indication of ADPKD. Also, the new dosage form of 30-mg Samsca tablets has received approval for the indication of ADPKD.
Morphotek Inc. announced today the issuance of United States Patent 6,982,169 covering the use of chemical inhibitors to enhance evolution of target host cell genomes by reversibly regulating mismatch repair (MMR) in vivo.
› Verified 3 days ago